• 132861+ Medical Conferences
  • 251 Specialties
  • 34920 Organizers
  • 148936 Speakers
  • 155 Countries
  • 4474 Cities
CME Conference Registrations Sold
Home  >  Conferences  >  4th Microbiome Movement Drug Development Summit

4th Microbiome Movement Drug Development Summit

Jun 26 - 28, 2019   |   Boston, Massachusetts  United States of America
Organized by : Hanson Wade
Conference Brochure

4th Microbiome Movement Drug Development Summit is organized by Hanson Wade and will be held from Jun 26 - 28, 2019 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

The study of the human microbiome remains one of the most exciting frontiers in modern medicine, that, if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective disease treatment through the microbiome is matched by the unique challenges in developing them. The 4th Microbiome Movement – Drug Development Summit returns to help cutting-edge pharmaceutical and academic researchers pursue the causal role of the human microbiome in disease to help deliver a new generation of targeted therapeutics, biomarker and diagnostics to patients that demonstrate consistent clinical outcomes and mechanisms of action.

So whether you’re part of a microbiome-focused biotech, a pharmaceutical organization assessing this exciting field, or an academic researcher with breakthrough findings, join the Microbiome Movement as we explore the global advances in translational microbiome research, and meet like-minded peers who are continuing to understand the causal and therapeutic potential of the human microbiome.

Hear from thought leaders and microbiome pioneers such as: Seres Therapeutics, Vedanta Biosciences, CoreBiome, Janssen Pharmaceuticals, Novome Biotechnologies, Microbiotica and 50 more. Visit the website to see the complete speaker faculty.

Pre-Conference Workshops: Jun 26, 2019
Main Conference: Jun 27 - 28, 2019

Artists / Speakers: Bernat Olle, CEO, Vedanta Biosciences, Dan Knights, CEO, CoreBiome, Esi Lamouse-Smith, Director, Janssen Pharmaceuticals, Liz Shepherd, Co-Founder, Novome Biotechnologies, Matthew Henn, EVP Microbiome R&D, Seres Therapeutics, Mike Romanos, CEO, Microbiotica, Mark Smith, CEO, Finch Therapeutics Group, Daniel van der Lelie, Chief Scientific Officer, Gusto Global, Julius Goepp, CEO, Scaled Microbiomics, Gregory Lambert, CEO, TargEDys, Colleen Cutcliffe, Co-Founder & CEO, Whole Biome

View All Speaking

Suguna Rachakonda
Suguna Rachakonda

Clinical Pharmacology

Ross O. Youngs
Ross O. Youngs

Immunology and Microbiology

Fyza Y. Shaikh
Fyza Y. Shaikh


Lothar Steidler
Lothar Steidler


Registration Desk

Contact No. : (+1) 617 455 4188


View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

Revere Hotel Boston Common
200 Stuart St
Boston, Massachusetts, United States of America

Official Hotel

Revere Hotel Boston Common,

200 Stuart Street,

Boston, Massachusetts, United States of America 02116,

+1 617 482 1800

Plan Your Travel


Please Rate this Conference


Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Hyatt Regency Boston Harbor
2.14 miles from venue
Price : USD 287.00 Per Night
Revere Hotel Boston Common
0.03 miles from venue
Price : USD 399.00 Per Night

Session Details

Session Topic Start Time End Time Location Description Speakers

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter


Subscribe to our newsletter and receive updates on medical conferences, board review courses and news